No Data
No Data
OptimizeRx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), OptimizeRx (OPRX) and AbbVie (ABBV)
OptimizeRx (OPRX) Stock Valuation Soars: Insights Unveiled
OptimizeRx Corp. (NASDAQ: OPRX) shares surged 14.32% to $10.06 on US stock exchanges today. The current-market rise followed a business update and preliminary financial results announcement, attracting attention from analysts and investors. OptimizeRx (OPRX) has released preliminary, unaudited financial statistics for many key performance indicators (KPIs) for the first quarter of 2024 in addition to ...
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Express News | OptimizeRx Corp Q1 Rev View $17.0 Mln -- Lseg Ibes Data
Express News | OptimizeRx Corp: For Q1, Company Expects Revenue to Increase Over 40% Year-Over-Year and Come in Between $18.5 Mln and $19.2 Mln
No Data